Ipca Laboratories Ltd 's Insider Trades & SAST Disclosures
No reported Insider Trades available for Ipca Laboratories Ltd in the Trendlyne database.
Ipca Laboratories Ltd 's has made SAST transactions in Lyka Labs Ltd. recently where a Acquisition of 2,600,000 shares done . Disclosure was reported to the exchange on April 17, 2024.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lyka Labs | Ipca Laboratories Ltd & PACs | Promoter | Acquisition | 22 Apr 2024 | 2,600,000 | 14,962,509 (41.93%) | 7.28% | - | 16 Apr 2024 16 Apr 2024 |
SAST (29(2)) | - | Conv. of Warrants | |
| Unichem Laboratories | Ipca Laboratories Ltd | Promoter | Acquisition | 26 Sep 2023 | 13,579,571 | 37,081,011 (52.67%) | 19.29% | - | 21 Sep 2023 21 Sep 2023 |
SAST (29(2)) | - | Open Offer | |
| Unichem Laboratories | Ipca Laboratories Ltd | Other | Acquisition | 03 Aug 2023 | 23,501,440 | 23,501,440 (33.38%) | 33.38% | - | 02 Aug 2023 02 Aug 2023 |
SAST (29(1)) | - | Block Deal | |
| Lyka Labs | Ipca Laboratories Ltd & PACs | Promoter | Acquisition | 20 Apr 2023 | 2,400,000 | 12,362,509 (37.44%) | 7.25% | - | 18 Apr 2023 18 Apr 2023 |
SAST (29(2)) | - | Conv. of Warrants | |
| Lyka Labs | Ipca Laboratories Ltd & PACs | Promoter | Acquisition | 17 Mar 2023 | 2,000,000 | 9,962,509 (32.46%) | 6.52% | - | 15 Mar 2023 15 Mar 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Lyka Labs | Ipca Laboratories Ltd & PACs | Promoter | Acquisition | 25 Feb 2022 | 781 | 7,962,509 (27.76%) | - | - | 23 Feb 2022 23 Feb 2022 |
SAST (29(2)) | - | Open Offer | |
| Lyka Labs | Ipca Laboratories Ltd | Other | Acquisition | 24 Nov 2021 | 7,624,142 | 7,961,728 (27.75%) | 26.57% | - | 22 Nov 2021 24 Nov 2021 |
SAST (29(1)) | - | Market | |
| Krebs Biochemicals | Ipca Laboratories Ltd | Promoter | Acquisition | 07 Apr 2021 | 1,940,000 | 10,705,195 (49.65%) | 9% | - | 06 Apr 2021 06 Apr 2021 |
SAST (29(2)) | - | Pref. Allotment | |
| Krebs Biochemicals | Ipca Laboratories Ltd | Promoter | Acquisition | 20 May 2020 | 1,620,000 | 8,765,195 (44.67%) | 4.98% | - | 20 May 2020 20 May 2020 |
SAST (29(2)) | - | Pref. Allotment |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.